Mediplantex National Pharmaceutical Joint Stock Company reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was VND 96,645.81 million compared to VND 97,355.3 million a year ago. Net income was VND 3,324.27 million compared to VND 3,428.93 million a year ago. Basic earnings per share from continuing operations was VND 306 compared to VND 290 a year ago.
For the six months, revenue was VND 183,524.21 million compared to VND 175,950.57 million a year ago. Net income was VND 4,294.4 million compared to net loss of VND 1,568.88 million a year ago. Basic earnings per share from continuing operations was VND 395 compared to basic loss per share from continuing operations of VND 167 a year ago.